These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4827361)

  • 21. [Mechanisms of action of oral contraceptives].
    Vihko R
    Duodecim; 1973 Oct; 89(24):1612-7. PubMed ID: 4358903
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prospects of using modern x-ray contrast substances for intravenous cholegraphy (a review of the literature)].
    Sviridov NK
    Vestn Rentgenol Radiol; 1981; (6):78-81. PubMed ID: 7036516
    [No Abstract]   [Full Text] [Related]  

  • 23. Drip infusion intravenous cholangiography.
    Margolin FR; Obata W
    Radiol Clin Biol; 1968; 37(6):353-6. PubMed ID: 5714065
    [No Abstract]   [Full Text] [Related]  

  • 24. The combined use of oral cholecystopaque media and iodipamide.
    Goergen T; Goldberger LE; Berk RN
    Radiology; 1974 Jun; 111(3):543-8. PubMed ID: 4828985
    [No Abstract]   [Full Text] [Related]  

  • 25. Determination of plasma levels of biliary contrast media.
    Fleck A; Caine S; Lucas J; Duncan JG
    Clin Radiol; 1974 Oct; 25(4):511-6. PubMed ID: 4442244
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous ionic contrast media cause local prostacyclin release in man.
    De Maeyer P; Deckmyn H; Arnout J; Baert AL; Vermylen J
    Invest Radiol; 1985 Nov; 20(8):871-3. PubMed ID: 3908384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase of subcapsular renal pressure after intravenous iodipamide and other parenteral contrast media. An experimental investigation.
    Lindgren P; Saltzman GF
    Acta Radiol Diagn (Stockh); 1974 May; 15(3):273-80. PubMed ID: 4858726
    [No Abstract]   [Full Text] [Related]  

  • 28. [Complication after intravenous administration of Bilignost in cholegraphy].
    Shubinskiĭ NA
    Vrach Delo; 1968 Nov; 11():120-1. PubMed ID: 5744880
    [No Abstract]   [Full Text] [Related]  

  • 29. [The uricosuric action of contrast media used for the opacification of bile ducts (apropos of 27 cases)].
    Billis A; Dimopoulos C; Giamarellou H; Zoumbouli I; Papadimitriou A; Sagiorgis G; Kaniouras N; Scouteris M; Daïcos G
    Ann Med Interne (Paris); 1973 Dec; 124(12):853-62. PubMed ID: 4598722
    [No Abstract]   [Full Text] [Related]  

  • 30. Usefulness of iotroxic acid for drip infusion cholegraphy -- comparison with iodoxamic acid preparations.
    Nakata H; Kimoto T; Matsuura K; Nishitani H; Baba H; Koga M; Kiyonari H; Tanaka M; Shiosaki H; Matsuoka J; Ayabe Y; Nakagawa E
    Br J Radiol; 1982 Aug; 55(656):610-1. PubMed ID: 6896837
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intravenous cholegraphy with biligram. Clinical pharmacology].
    Taenzer V; Herms HJ
    Fortschr Geb Rontgenstr Nuklearmed; 1971 Jan; 114(1):102-7. PubMed ID: 5099735
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical evaluation of a new contrast medium for cholegraphy].
    Németh A
    Schweiz Rundsch Med Prax; 1976 Jul; 65(27):846-52. PubMed ID: 1036621
    [No Abstract]   [Full Text] [Related]  

  • 33. Iosulamide: a new intravenous cholangiocholecystographic medium.
    Rosenberg FJ; Ackerman JH; Nickel AR
    Invest Radiol; 1980; 15(6 Suppl):S142-7. PubMed ID: 6782035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Problems related to the radiographic study of the biliary tract using oral or intravenous contrast media. Main side effects and biochemical changes induced by the administration of contrast media].
    Limido G
    Minerva Dietol Gastroenterol; 1984; 30(1):9-15. PubMed ID: 6374500
    [No Abstract]   [Full Text] [Related]  

  • 35. Tolerability of iohexol after injection into healthy volunteers.
    Levorstad K; Kolbenstvedt A; Kolmannskog F; Sommerfelt SC; Stormorken H; Andrew E; Sveen K
    Acta Radiol Diagn (Stockh); 1983; 24(3):241-51. PubMed ID: 6624528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of various oral gestagens on liver function.
    Okamura H
    J Jpn Obstet Gynecol Soc; 1968 Jul; 15(3):177-93. PubMed ID: 5705316
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety and pharmacokinetics of ioversol in healthy volunteers.
    Wilkins RA; Whittington JR; Brigden GS; Lahiri A; Heber ME; Hughes LO
    Invest Radiol; 1989 Oct; 24(10):781-8. PubMed ID: 2793391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cholecysto-cholangiography with special reference to oral and intravenous methods].
    Shinoara S; Akazaki I
    Saishin Igaku; 1970 Nov; 25(11):2267-74. PubMed ID: 4920650
    [No Abstract]   [Full Text] [Related]  

  • 39. Endometrial carbonic anhydrase after diethylstilbestrol as a postcoital antifertility agent.
    Board JA
    Obstet Gynecol; 1970 Sep; 36(3):347-9. PubMed ID: 4988962
    [No Abstract]   [Full Text] [Related]  

  • 40. [The characteristics of triphasic estrogen-progesterone contraceptives and their theoretical indications].
    Senèze J
    Rev Fr Gynecol Obstet; 1990 May; 85(5):301-5. PubMed ID: 2374864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.